Emergent BioSolutions

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EBS and other ETFs, options, and stocks.

About EBS

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It operates through the following segments: Commercial Product Sales, MCM Product Sales, and Services. 

CEO
Joseph C. Papa
CEOJoseph C. Papa
Employees
900
Employees900
Headquarters
Gaithersburg, Maryland
HeadquartersGaithersburg, Maryland
Founded
1998
Founded1998
Employees
900
Employees900

EBS Key Statistics

Market cap
317.89M
Market cap317.89M
Price-Earnings ratio
-1.75
Price-Earnings ratio-1.75
Dividend yield
Dividend yield
Average volume
1.12M
Average volume1.12M
High today
$6.29
High today$6.29
Low today
$6.10
Low today$6.10
Open price
$6.26
Open price$6.26
Volume
998.48K
Volume998.48K
52 Week high
$14.06
52 Week high$14.06
52 Week low
$4.36
52 Week low$4.36

Stock Snapshot

With a market cap of 317.89M, Emergent BioSolutions(EBS) trades at $6.10. The stock has a price-to-earnings ratio of -1.75.

On 2026-09-06, Emergent BioSolutions(EBS) stock traded between a low of $6.10 and a high of $6.29. Shares are currently priced at $6.10, which is 0.0% above the low and -3.0% below the high.

The Emergent BioSolutions(EBS)'s current trading volume is 998.48K, compared to an average daily volume of 1.12M.

During the past year, Emergent BioSolutions(EBS) stock moved between $4.36 at its lowest and $14.06 at its peak.

During the past year, Emergent BioSolutions(EBS) stock moved between $4.36 at its lowest and $14.06 at its peak.

EBS News

Investing.com 3d
Emergent BioSolutions repurchases $75 million in senior notes - investing.com

...

Emergent BioSolutions repurchases $75 million in senior notes - investing.com
TipRanks 5d
Emergent BioSolutions Secures New BARDA Anthrax Contract

Emergent Biosolutions ( (EBS) ) has issued an announcement. Emergent BioSolutions, a biopharmaceutical company specializing in biodefense and medical counterme...

TipRanks 5d
Emergent BioSolutions announces $24M modification from BARDA

Emergent BioSolutions (EBS) announced a contract modification valued at approximately $24M from the Biomedical Advanced Research and Development Authority, part...

More EBS News

TipRanks 6d
Emergent awarded standing offer by Government of Canada for Narcan Nasal Spray

Emergent BioSolutions (EBS) announced that it has been awarded a standing offer by the Government of Canada, through a competitive procurement process, to suppl...

People also own

Based on the portfolios of people who own EBS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.